SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
-19.28%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$85.9M
AUM Growth
+$85.9M
(-17%)
Cap. Flow
+$1.38M
Cap. Flow
% of AUM
1.6%
Top 10 Holdings %
Top 10 Hldgs %
58.4%
Holding
67
New
17
Increased
15
Reduced
14
Closed
19
Top Buys
| 1 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$4.03M |
| 2 |
Zynex
ZYXI
|
$3.86M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$3.23M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
$2.04M |
| 5 |
AbbVie
ABBV
|
$2.02M |
Top Sells
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
$6.91M |
| 2 |
DERM
Dermira, Inc.
DERM
|
$2.5M |
| 3 |
AGN
Allergan plc
AGN
|
$2.46M |
| 4 |
Humana
HUM
|
$2.13M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$2.11M |
Sector Composition
| 1 | Healthcare | 97.9% |
| 2 | Real Estate | 1.33% |
| 3 | Communication Services | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ESSA Pharma
EPIX
$11.4M
| $8.32M | 9.68% | 2,080,421 +446,052 | +27% | +$1.78M |
|
2
Grifois
GRFS
$6.78B
| $7.8M | 9.07% | 387,035 -65,865 | -15% | -$1.33M |
|
|
ISEE
3
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.53M | 6.43% | 1,607,153 +938,782 | +140% | +$3.23M |
|
|
HARP
4
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $5.45M | 6.35% | 470,926 +347,726 | +282% | +$4.03M |
|
5
iRadimed
IRMD
$921M
| $5.01M | 5.83% | 234,810 +94,058 | +67% | +$2.01M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.29M | 4.99% | 47,800 +16,500 | +53% | +$1.48M |
|
|
7
Zynex
ZYXI
$49.7M
| $3.86M | 4.49% | +348,564 | New | +$3.86M |
|
8
DexCom
DXCM
$29.5B
| $3.62M | 4.21% | 13,450 -4,150 | -24% | -$1.12M |
|
9
Vericel Corp
VCEL
$1.83B
| $3.23M | 3.76% | 352,332 +168,652 | +92% | +$1.55M |
|
10
Adverum Biotechnologies
ADVM
$64.6M
| $3.07M | 3.57% | 313,900 -28,900 | -8% | -$282K |
|
|
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.76M | 3.21% | 405,207 +199,800 | +97% | +$1.36M |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $2.59M | 3.01% | 14,600 -13,900 | -49% | -$2.46M |
|
13
Spyre Therapeutics
SYRE
$996M
| $2.5M | 2.91% | 536,497 +78,332 | +17% | +$365K |
|
|
MSON
14
DELISTED
Misonix Inc
MSON
| $2.25M | 2.61% | 238,333 +59,737 | +33% | +$563K |
|
15
Zymeworks
ZYME
$1.12B
| $2.18M | 2.54% | 61,528 +38,828 | +171% | +$1.38M |
|
|
ATRS
16
DELISTED
Antares Pharma, Inc.
ATRS
| $2.04M | 2.37% | +864,100 | New | +$2.04M |
|
|
17
AbbVie
ABBV
$372B
| $2.02M | 2.35% | +26,500 | New | +$2.02M |
|
18
UnitedHealth
UNH
$281B
| $1.97M | 2.29% | +7,900 | New | +$1.97M |
|
|
AXNX
19
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.6M | 1.86% | +63,000 | New | +$1.6M |
|
|
ITMR
20
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $1.35M | 1.57% | +114,865 | New | +$1.35M |
|
21
Rafael Holdings
RFL
$51.6M
| $1.14M | 1.33% | 89,131 +51,206 | +135% | +$656K |
|
|
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.08M | 1.25% | 257,141 -93,159 | -27% | -$390K |
|
23
Larimar Therapeutics
LRMR
$310M
| $1.04M | 1.21% | 1,348,399 +544,436 | +68% | +$419K |
|
24
Biogen
BIIB
$19.4B
| $949K | 1.1% | 3,000 -4,500 | -60% | -$1.42M |
|
25
Establishment Labs
ESTA
$1.2B
| $914K | 1.06% | 63,254 -30,306 | -32% | -$438K |
|